ABBV vs CI
By Alex · Tickerpine
AbbVie Inc. vs The Cigna Group, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | CI |
|---|---|---|
| Price | $285.64 | $306.95 |
| Market cap | $504.76B | $81.11B |
| P/E ratio | 80.5 | 12.7 |
| ROE | — | 16.76% |
| Profit margin | 9.80% | 2.27% |
| Revenue growth | 10.20% | 6.70% |
| Dividend yield | 2.42% | 2.03% |
| Beta | 0.23 | 0.30 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs CI in plain English
- ABBV is the bigger company — about 6.2× the market cap of CI.
- CI is cheaper on earnings (P/E 12.7 vs 80.5).
- ABBV is growing revenue faster (10% vs 7%).
- ABBV has the higher dividend yield (2.42% vs 2.03%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
CI return calculator
See what $1,000 in The Cigna Group would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.